ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies

Jean Pegliasco; Barbara Schmaltz-Panneau; Jean Edouard Martin; Samy Chraibi; Sabine Khalife-Hachem; Flore Salviat; Florence Pasquier; Christophe Willekens; Maureen Lopez; Adel Ben-ali; Odile Bera; Olivier Caron; Cristina Castilla-Llorent; Sophie Cotteret; Carole Bourdin; Veronique Saada; Nathalie Auger; Stephane de Botton; William Vainchenker; Pascal Fuseau; Philippe Helias; Raouf Benabdelali; Christophe Marzac; Jean Come Meniane; Isabelle Plo; Christine Bellanné-Chantelot; Jean Baptiste Micol

doi:10.1080/10428194.2021.1881508

ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies

Jean Pegliasco, Barbara Schmaltz-Panneau, Jean Edouard Martin, Samy Chraibi, Sabine Khalife-Hachem, Flore Salviat, Florence Pasquier, Christophe Willekens, Maureen Lopez, Adel Ben-ali, Odile Bera, Olivier Caron, Cristina Castilla-Llorent, Sophie Cotteret, Carole Bourdin, Veronique Saada, Nathalie Auger, Stephane de Botton, William Vainchenker, Pascal FuseauPhilippe Helias, Raouf Benabdelali, Christophe Marzac, Jean Come Meniane, Isabelle Plo, Christine Bellanné-Chantelot, Jean Baptiste Micol

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

5 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	1770-1773
Nombre de pages	4
journal	Leukemia and Lymphoma
Volume	62
Numéro de publication	7
Les DOIs	https://doi.org/10.1080/10428194.2021.1881508
état	Publié - 1 janv. 2021

Accès au document

10.1080/10428194.2021.1881508

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Pegliasco, J., Schmaltz-Panneau, B., Martin, J. E., Chraibi, S., Khalife-Hachem, S., Salviat, F., Pasquier, F., Willekens, C., Lopez, M., Ben-ali, A., Bera, O., Caron, O., Castilla-Llorent, C., Cotteret, S., Bourdin, C., Saada, V., Auger, N., de Botton, S., Vainchenker, W., ... Micol, J. B. (2021). ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies. Leukemia and Lymphoma, 62(7), 1770-1773. https://doi.org/10.1080/10428194.2021.1881508

@article{3f0467a0621546ee9a5a4cae9313f72b,

title = "ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies",

author = "Jean Pegliasco and Barbara Schmaltz-Panneau and Martin, {Jean Edouard} and Samy Chraibi and Sabine Khalife-Hachem and Flore Salviat and Florence Pasquier and Christophe Willekens and Maureen Lopez and Adel Ben-ali and Odile Bera and Olivier Caron and Cristina Castilla-Llorent and Sophie Cotteret and Carole Bourdin and Veronique Saada and Nathalie Auger and {de Botton}, Stephane and William Vainchenker and Pascal Fuseau and Philippe Helias and Raouf Benabdelali and Christophe Marzac and Meniane, {Jean Come} and Isabelle Plo and Christine Bellann{\'e}-Chantelot and Micol, {Jean Baptiste}",

note = "Funding Information: J. B. M. received honoraria from Abbvie, Jazz Pharmaceuticals, and Astellas. S. D. B. received honoraria from Agios, Celgene, Forma Therapeutics, Abbvie, Astellas, Daichi, Novartis, Pfizer and Jazz Pharmaceuticals and has received research funding from Agios and Forma Therapeutics. C. M. received honoraria from Astellas. W. C. received personal fee from Qiagen. P. H. received honoraria from Novartis Pharma, Amgen and non-financial support from Novartis Pharma, Amgen, Celgene, Janssen-Cilag and Roche. Funding Information: Institut National du Cancer (Plbio 2017) and Association pour la Recherche sur le Cancer (PGA 2020).",

year = "2021",

month = jan,

day = "1",

doi = "10.1080/10428194.2021.1881508",

language = "English",

volume = "62",

pages = "1770--1773",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "7",

}

Pegliasco, J, Schmaltz-Panneau, B, Martin, JE, Chraibi, S, Khalife-Hachem, S, Salviat, F, Pasquier, F, Willekens, C, Lopez, M, Ben-ali, A, Bera, O, Caron, O, Castilla-Llorent, C, Cotteret, S, Bourdin, C, Saada, V, Auger, N, de Botton, S, Vainchenker, W, Fuseau, P, Helias, P, Benabdelali, R, Marzac, C, Meniane, JC, Plo, I, Bellanné-Chantelot, C & Micol, JB 2021, 'ATG2B/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies', Leukemia and Lymphoma, VOL. 62, Numéro 7, p. 1770-1773. https://doi.org/10.1080/10428194.2021.1881508

TY - JOUR

T1 - ATG2B/GSKIP in de novo acute myeloid leukemia (AML)

T2 - high prevalence of germline predisposition in French West Indies

AU - Pegliasco, Jean

AU - Schmaltz-Panneau, Barbara

AU - Martin, Jean Edouard

AU - Chraibi, Samy

AU - Khalife-Hachem, Sabine

AU - Salviat, Flore

AU - Pasquier, Florence

AU - Willekens, Christophe

AU - Lopez, Maureen

AU - Ben-ali, Adel

AU - Bera, Odile

AU - Caron, Olivier

AU - Castilla-Llorent, Cristina

AU - Cotteret, Sophie

AU - Bourdin, Carole

AU - Saada, Veronique

AU - Auger, Nathalie

AU - de Botton, Stephane

AU - Vainchenker, William

AU - Fuseau, Pascal

AU - Helias, Philippe

AU - Benabdelali, Raouf

AU - Marzac, Christophe

AU - Meniane, Jean Come

AU - Plo, Isabelle

AU - Bellanné-Chantelot, Christine

AU - Micol, Jean Baptiste

N1 - Funding Information: J. B. M. received honoraria from Abbvie, Jazz Pharmaceuticals, and Astellas. S. D. B. received honoraria from Agios, Celgene, Forma Therapeutics, Abbvie, Astellas, Daichi, Novartis, Pfizer and Jazz Pharmaceuticals and has received research funding from Agios and Forma Therapeutics. C. M. received honoraria from Astellas. W. C. received personal fee from Qiagen. P. H. received honoraria from Novartis Pharma, Amgen and non-financial support from Novartis Pharma, Amgen, Celgene, Janssen-Cilag and Roche. Funding Information: Institut National du Cancer (Plbio 2017) and Association pour la Recherche sur le Cancer (PGA 2020).

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://www.scopus.com/inward/record.url?scp=85100790854&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.1881508

DO - 10.1080/10428194.2021.1881508

M3 - Letter

C2 - 33554699

AN - SCOPUS:85100790854

SN - 1042-8194

VL - 62

SP - 1770

EP - 1773

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 7

ER -